Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial

Abstract Background Tuberculosis (TB) is the leading cause of mortality among people living with HIV (PLHIV), despite the availability of effective preventive therapy. The TEKO trial is assessing the impact of using a blood test, Quantiferon-TB Gold In-Tube Test (QGIT), to screen for latent TB compa...

Full description

Bibliographic Details
Main Authors: Deanna Kerrigan, Carrie Tudor, Katlego Motlhaoleng, Limakatso Lebina, Cokiswa Qomfu, Ebrahim Variava, Sandy Chon, Neil Martinson, Jonathan E. Golub
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Health Services Research
Subjects:
TB
HIV
TST
Online Access:http://link.springer.com/article/10.1186/s12913-018-3088-8